Tianjin Medical Journal ›› 2023, Vol. 51 ›› Issue (10): 1048-1053.doi: 10.11958/20230156
• Cell and Molecular Biology • Previous Articles Next Articles
HUANG Chunyan(), XIANG Mi, FEI Zhiyi, GAO Qin
Received:
2023-02-15
Revised:
2023-05-13
Published:
2023-10-15
Online:
2023-10-18
HUANG Chunyan, XIANG Mi, FEI Zhiyi, GAO Qin. Influence of circACTR2 on high glucose-induced trophoblast cell injury by regulating miR-23a-3p/TBL1X axis[J]. Tianjin Medical Journal, 2023, 51(10): 1048-1053.
CLC Number:
组别 | circACTR2 | miR-23a-3p |
---|---|---|
NG组 | 1.00±0.00 | 1.00±0.00 |
HG组 | 1.62±0.14a | 0.47±0.08a |
si-NC组 | 1.61±0.15 | 0.48±0.07 |
si-circACTR2组 | 1.15±0.12bc | 0.83±0.06bc |
si-circACTR2+inhibitor-NC组 | 1.16±0.13 | 0.82±0.04 |
si-circACTR2+ miR-23a-3p inhibitor组 | 1.15±0.14 | 0.64±0.06de |
F | 27.181** | 80.931** |
Tab.1 Comparison of expression of circACTR2 and miR-23a-3p in HTR-8/Svneo cells between the six groups
组别 | circACTR2 | miR-23a-3p |
---|---|---|
NG组 | 1.00±0.00 | 1.00±0.00 |
HG组 | 1.62±0.14a | 0.47±0.08a |
si-NC组 | 1.61±0.15 | 0.48±0.07 |
si-circACTR2组 | 1.15±0.12bc | 0.83±0.06bc |
si-circACTR2+inhibitor-NC组 | 1.16±0.13 | 0.82±0.04 |
si-circACTR2+ miR-23a-3p inhibitor组 | 1.15±0.14 | 0.64±0.06de |
F | 27.181** | 80.931** |
组别 | 24 h | 48 h | 72 h |
---|---|---|---|
NG组 | 1.05±0.12 | 1.26±0.13 | 1.54±0.14 |
HG组 | 0.51±0.06a | 0.63±0.08a | 0.82±0.11a |
si-NC组 | 0.52±0.07 | 0.64±0.07 | 0.83±0.13 |
si-circACTR2组 | 0.88±0.05bc | 1.02±0.05bc | 1.24±0.06bc |
si-circACTR2+inhibitor- NC组 | 0.89±0.07 | 1.01±0.06 | 1.23±0.08 |
si-circACTR2+ miR-23a-3p inhibitor组 | 0.67±0.06de | 0.85±0.07de | 1.04±0.07de |
F | 51.681** | 54.934** | 43.465** |
Tab.2 Comparison of proliferative ability of HTR-8/Svneo cells between the six groups
组别 | 24 h | 48 h | 72 h |
---|---|---|---|
NG组 | 1.05±0.12 | 1.26±0.13 | 1.54±0.14 |
HG组 | 0.51±0.06a | 0.63±0.08a | 0.82±0.11a |
si-NC组 | 0.52±0.07 | 0.64±0.07 | 0.83±0.13 |
si-circACTR2组 | 0.88±0.05bc | 1.02±0.05bc | 1.24±0.06bc |
si-circACTR2+inhibitor- NC组 | 0.89±0.07 | 1.01±0.06 | 1.23±0.08 |
si-circACTR2+ miR-23a-3p inhibitor组 | 0.67±0.06de | 0.85±0.07de | 1.04±0.07de |
F | 51.681** | 54.934** | 43.465** |
组别 | MDA/(μmol/L) | LDH/(U/L) | SOD/(U/mL) |
---|---|---|---|
NG组 | 5.23±0.46 | 11.37±1.15 | 28.76±2.35 |
HG组 | 24.36±2.15a | 36.54±2.32a | 8.54±1.24a |
si-NC组 | 23.74±2.13 | 35.83±2.16 | 9.36±1.32 |
si-circACTR2组 | 13.86±1.54bc | 17.46±2.21bc | 21.68±2.21bc |
si-circACTR2+ inhibitor-NC组 | 12.78±1.46 | 18.52±2.14 | 22.75±2.15 |
si-circACTR2+ miR- 23a-3p inhibitor组 | 19.43±1.37de | 24.36±2.13de | 17.58±2.14de |
F | 123.683** | 150.307** | 99.442** |
Tab.3 Comparison of MDA level, LDH, SOD activities of HTR-8/Svneo cells between the six groups
组别 | MDA/(μmol/L) | LDH/(U/L) | SOD/(U/mL) |
---|---|---|---|
NG组 | 5.23±0.46 | 11.37±1.15 | 28.76±2.35 |
HG组 | 24.36±2.15a | 36.54±2.32a | 8.54±1.24a |
si-NC组 | 23.74±2.13 | 35.83±2.16 | 9.36±1.32 |
si-circACTR2组 | 13.86±1.54bc | 17.46±2.21bc | 21.68±2.21bc |
si-circACTR2+ inhibitor-NC组 | 12.78±1.46 | 18.52±2.14 | 22.75±2.15 |
si-circACTR2+ miR- 23a-3p inhibitor组 | 19.43±1.37de | 24.36±2.13de | 17.58±2.14de |
F | 123.683** | 150.307** | 99.442** |
组别 | TBL1X | PCNA | MMP-2 | MMP-9 | caspase-3 |
---|---|---|---|---|---|
NG组 | 0.47±0.08 | 1.24±0.15 | 1.51±0.16 | 1.36±0.14 | 0.72±0.06 |
HG组 | 1.16±0.12a | 0.53±0.07a | 0.67±0.08a | 0.58±0.06a | 1.52±0.14a |
si-NC组 | 1.15±0.13 | 0.54±0.08 | 0.68±0.07 | 0.59±0.08 | 1.51±0.15 |
si-circACTR2组 | 0.63±0.07bc | 0.96±0.12bc | 1.23±0.14bc | 1.02±0.11bc | 1.04±0.08bc |
si-circACTR2+inhibitor-NC组 | 0.64±0.05 | 0.95±0.13 | 1.22±0.13 | 1.01±0.12 | 1.03±0.07 |
si-circACTR2+miR-23a-3p inhibitor组 | 0.82±0.06de | 0.76±0.06de | 0.93±0.08de | 0.79±0.07de | 1.25±0.09de |
F | 61.368** | 39.658** | 51.248** | 52.912** | 53.429** |
Tab.4 Comparison of protein expression of TBL1X, PCNA, MMP-2, MMP-9 and caspase-3 in HTR-8/Svneo cells between the six groups
组别 | TBL1X | PCNA | MMP-2 | MMP-9 | caspase-3 |
---|---|---|---|---|---|
NG组 | 0.47±0.08 | 1.24±0.15 | 1.51±0.16 | 1.36±0.14 | 0.72±0.06 |
HG组 | 1.16±0.12a | 0.53±0.07a | 0.67±0.08a | 0.58±0.06a | 1.52±0.14a |
si-NC组 | 1.15±0.13 | 0.54±0.08 | 0.68±0.07 | 0.59±0.08 | 1.51±0.15 |
si-circACTR2组 | 0.63±0.07bc | 0.96±0.12bc | 1.23±0.14bc | 1.02±0.11bc | 1.04±0.08bc |
si-circACTR2+inhibitor-NC组 | 0.64±0.05 | 0.95±0.13 | 1.22±0.13 | 1.01±0.12 | 1.03±0.07 |
si-circACTR2+miR-23a-3p inhibitor组 | 0.82±0.06de | 0.76±0.06de | 0.93±0.08de | 0.79±0.07de | 1.25±0.09de |
F | 61.368** | 39.658** | 51.248** | 52.912** | 53.429** |
[1] | HUA Z, LI D, WU A, et al. miR-377 inhibition enhances the survival of trophoblast cells via upregulation of FNDC5 in gestational diabetes mellitus[J]. Open Med (Wars), 2021, 16(1):464-471. doi:10.1515/med-2021-0247. |
[2] | PÉREZ-PÉREZ A, VILARIÑO-GARCÍA T, GUADIX P, et al. Leptin and Nutrition in gestational diabetes[J]. Nutrients, 2020, 12(7):1970. doi:10.3390/nu12071970. |
[3] | TAN H X, YANG S L, LI M Q, et al. Autophagy suppression of trophoblast cells induces pregnancy loss by activating decidual NK cytotoxicity and inhibiting trophoblast invasion[J]. Cell Commun Signal, 2020, 18(1):73. doi:10.1186/s12964-020-00579-w. |
[4] | SHANG J, LIN L, HUANG X, et al. Re-expression of circ_0043610 contributes to trophoblast dysfunction through the miR-558/RYBP pathway in preeclampsia[J]. Endocr J, 2022, 69(12):1373-1385. doi:10.1507/endocrj.EJ22-0153. |
[5] | ZHU C, LIU Y, WU H. Overexpression of circACTR2 in gestational diabetes mellitus predicts intrauterine death,fetal malformation,and intrauterine infection[J]. Diabetes Metab Syndr Obes, 2021, 14:4655-4660. doi:10.2147/DMSO.S316043. |
[6] | ZHENG T, CHEN H. Resveratrol ameliorates the glucose uptake and lipid metabolism in gestational diabetes mellitus mice and insulin-resistant adipocytes via miR-23a-3p/NOV axis[J]. Mol Immunol, 2021, 137:163-173. doi:10.1016/j.molimm.2021.06.011. |
[7] | DING R, GUO F, ZHANG Y, et al. Integrated transcriptome sequencing analysis reveals role of miR-138-5p/TBL1X in placenta from gestational diabetes mellitus[J]. Cell Physiol Biochem, 2018, 51(2):630-646. doi:10.1159/000495319. |
[8] | 田雨青, 任宏丽, 梁阿娟. 黄芩苷通过调控miR-451对高糖诱导滋养层细胞损伤的保护作用[J]. 中成药, 2022, 44(4):1314-1317. |
TIAN Y Q, REN H L, LIANG A J. Protective effect of baicalin on trophoblast cell damage induced by high glucose by regulating miR-451[J]. China Journal of Chinese Materia Medica, 2022, 44(4):1314-1317. doi:10.3969/j.issn.1001-1528.2022.04.053. | |
[9] | FISHER J J, VANDERPEET CL, BARTHO LA, et al. Mitochondrial dysfunction in placental trophoblast cells experiencing gestational diabetes mellitus[J]. J Physiol, 2021, 599(4):1291-1305. doi:10.1113/JP280593. |
[10] | 李琴, 谢莹莺. 胰岛素生长因子2甲基化对高糖诱导滋养层细胞凋亡及PI3K/Akt通路的影响[J]. 安徽医科大学学报, 2020, 55(5):665-670. |
LI Q, XIE Y Y. Effects of insulin growth factor 2 methylation on high glucose induced trophoblast cell apoptosis and PI3K/Akt pathway[J]. Acta Universitatis Medicinalis Anhui, 2020, 55(5):665-670. doi:10.19405/j.cnki.issn1000-1492.2020.05.003. | |
[11] | BAO D, ZHUANG C, JIAO Y, et al. The possible involvement of circRNA DMNT1/p53/JAK/STAT in gestational diabetes mellitus and preeclampsia[J]. Cell Death Discov, 2022, 8(1):121. doi:10.1038/s41420-022-00913-w. |
[12] | CHEN H, ZHANG S, WU Y, et al. The role of circular RNA circ_0008285 in gestational diabetes mellitus by regulating the biological functions of trophoblasts[J]. Biol Res, 2021, 54(1):14. doi:10.1186/s40659-021-00337-3. |
[13] | WANG H, ZHOU W, SHE G, et al. Downregulation of hsa_circ_0005243 induces trophoblast cell dysfunction and inflammation via the β-catenin and NF-κB pathways[J]. Reprod Biol Endocrinol, 2020, 18(1):51. doi:10.1186/s12958-020-00612-0. |
[14] | WEN S, LI S, LI L, et al. circACTR2:A novel mechanism regulating high glucose-induced fibrosis in renal tubular cells via pyroptosis[J]. Biol Pharm Bull, 2020, 43(3):558-564. doi:10.1248/bpb.b19-00901. |
[15] | 陈春来, 王毅, 舒静. microRNA-195-5p在妊娠糖尿病患者血浆中的表达及其对细胞增殖和凋亡的影响[J]. 中国临床药理学杂志, 2021, 37(18):2397-2400. |
CHEN C L, WANG Y, SHU J. Expression of microRNA-195-5p in plasma of pregnant women with diabetes and its effect on cell proliferation and apoptosis[J]. The Chinese Journal of Clinical Pharmacology, 2021, 37(18):2397-2400. doi:10.13699/j.cnki.1001-6821.2021.18.004. | |
[16] | WANG J, PAN Y, DAI F, et al. Serum miR-195-5p is upregulated in gestational diabetes mellitus[J]. J Clin Lab Anal, 2020, 34(8):e23325. doi:10.1002/jcla.23325. |
[17] | ZHANG L, ZENG M, TANG F, et al. Circ-PNPT1 contributes to gestational diabetes mellitus (GDM) by regulating the function of trophoblast cells through miR-889-3p/PAK1 axis[J]. Diabetol Metab Syndr, 2021, 13(1):58. doi:10.1186/s13098-021-00678-9. |
[18] | LI Y, ZHUANG J. miR-345-3p serves a protective role during gestational diabetes mellitus by targeting BAK1[J]. Exp Ther Med, 2021, 21(1):2. doi:10.3892/etm.2020.9434. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||